ScholarIQanswers from OpenAlex

Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis

PaperCitations, authors & open-access status

Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis have?

ScholarIQcitation count

Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis has 112 citations in the OpenAlex counts ScholarIQ stores.

When was Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis published?

ScholarIQyear

Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis has 2015 year in the ScholarIQ index.

What is the open-access status of Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis?

ScholarIQoa status

Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis has closed oa status in the ScholarIQ index.

What is the DOI of Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis?

ScholarIQdoi

The DOI for Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis is on the source record.

What is the PMID of Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis?

ScholarIQpmid

The PMID for Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis is on the source record.

What is the OpenAlex record for Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis?

ScholarIQopenalex

The OpenAlex for Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial